Search Results - "Lonie, Jane A"

Screening for mild cognitive impairment: a systematic review by Lonie, Jane A., Tierney, Kevin M., Ebmeier, Klaus P.

“…Objective Patients with mild cognitive impairment account for a significant number of referrals to old age psychiatry services and specialist memory clinics…”
Get full text

MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging by Sexton, Claire E, Mackay, Clare E, Lonie, Jane A, Bastin, Mark E, Terrière, Emma, O'Carroll, Ronan E, Ebmeier, Klaus P

“…Abstract Episodic memory is a core feature of Alzheimer's disease (AD) and mild cognitive impairment (MCI). Impaired episodic memory in AD results from the…”
Get full text

Predicting outcome in mild cognitive impairment: 4-year follow-up study by Lonie, Jane A, Parra-Rodriguez, Mario A, Tierney, Kevin M, Herrmann, Lucie L, Donaghey, Claire, O'Carroll, Ronan E, Ebmeier, Klaus P

“…Cognitive impairment precedes the diagnosis of Alzheimer's disease. It is unclear which psychometric measures predict dementia, and what cut-off points should…”
Get full text

Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer's disease by Lonie, Jane A., Herrmann, Lucie L., Tierney, Kevin M., Donaghey, Claire, O'Carroll, Ronan, Lee, Andrew, Ebmeier, Klaus P.

“…Episodic memory is compromised in amnestic mild cognitive impairment (aMCI), but lesser deficits in other cognitive domains are also commonly observed and may…”
Get full text

Clinical referral patterns and cognitive profile in mild cognitive impairment by Lonie, Jane A, Herrmann, Lucie L, Donaghey, Claire L, Ebmeier, Klaus P

“…There is current interest in exploring the different subtypes of mild cognitive impairment (MCI), in terms of both their epidemiology and their cognitive…”
Get full text

5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment by Terrière, Emma, Dempsey, Mary F, Herrmann, Lucie L, Tierney, Kevin M, Lonie, Jane A, O'Carroll, Ronan E, Pimlott, Sally, Wyper, David J, Herholz, Karl, Ebmeier, Klaus P

“…Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of…”
Get full text

5- 123I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment by Terrière, Emma, Dempsey, Mary F., Herrmann, Lucie L., Tierney, Kevin M., Lonie, Jane A., O’Carroll, Ronan E., Pimlott, Sally, Wyper, David J., Herholz, Karl, Ebmeier, Klaus P.

“…Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of…”
Get full text

5- super(123)I-A-85380 binding to the a4b2-nicotinic receptor in mild cognitive impairment by Terriere, Emma, Dempsey, Mary F, Herrmann, Lucie L, Tierney, Kevin M, Lonie, Jane A, O'Carroll, Ronan E, Pimlott, Sally, Wyper, David J, Herholz, Karl, Ebmeier, Klaus P

“…Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of…”
Get full text

Predicting outcome in mild cognitive impairment: 4-year follow-up study by LONIE, Jane A, PARRA-RODRIGUEZ, Mario A, TIERNEY, Kevin M, HERRMANN, Lucie L, DONAGHEY, Claire, O'CARROLL, Ronan E, EBMEIER, Klaus P

Get full text

Clinical referral patterns and cognitive profile in mildcognitive impairment by Lonie, Jane A, Herrmann, Lucie L, Donaghey, Claire L, Ebmeier, Klaus P

“…BackgroundThere is current interest in exploring the different subtypes of mildcognitive impairment (MCI), in terms of both their epidemiology and…”
Get full text

Clinical referral patterns and cognitive profile in mild cognitive impairment by LONIE, Jane A, HERRMANN, Lucie L, DONAGHEY, Claire L, EBMEIER, Klaus P

Get full text

5-123 I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment by Terrière, Emma, Dempsey, Mary F, Herrmann, Lucie L, Tierney, Kevin M, Lonie, Jane A, O’Carroll, Ronan E, Pimlott, Sally, Wyper, David J, Herholz, Karl, Ebmeier, Klaus P

“…Abstract Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early…”
Get full text